Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (521-530 of 933) with videos related to

Pageof 94
Sort By:
Gynecologic Oncology|February 19, 2017
Genetic risk factors for ovarian cancer and their role for endometriosis riskStefanie Burghaus, Peter A Fasching, Lothar Häberle, et al.
International Urology and Nephrology|December 31, 2016
WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approachWolfgang Otto, Johannes Breyer, Sonja Herdegen, et al.
Cancers|September 28, 2024
Tumor-Associated Neutrophils Are a Negative Prognostic Factor in Early Luminal Breast Cancers Lacking Immunosuppressive Macrophage RecruitmentEva Schmidt, Luitpold Distel, Ramona Erber, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|March 3, 2018
Initial clinical results with a fusion prototype for mammography and three-dimensional ultrasound with a standard mammography system and a standard ultrasound probeJulius Emons, Marius Wunderle, Arndt Hartmann, et al.
Oncology|March 14, 2015
Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09)Günter Niegisch, Margitta Retz, Mark Thalgott, et al.
International Journal of Molecular Sciences|September 23, 2022
Improved Bladder Tumor RNA Isolation from Archived Tissues Using Methylene Blue for Normalization, Multiplex RNA Hybridization, Sequencing and SubtypingStefanie A Köhler, Lisa Brandl, Pamela L Strissel, et al.
Cancers|January 1, 2020
Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer PatientsAmer Abdulrahman, Markus Eckstein, Rudolf Jung, et al.
The American Journal of Surgical Pathology|October 9, 2015
Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic MarkerAbbas Agaimy, Katja Specht, Robert Stoehr, et al.
Geburtshilfe Und Frauenheilkunde|July 18, 2017
A Standard Mammography Unit - Standard 3D Ultrasound Probe Fusion Prototype: First ResultsRüdiger Schulz-Wendtland, Sebastian M Jud, Peter A Fasching, et al.
BMC Cancer|March 22, 2014
Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective studyAnja Rogler, Sabine Hoja, Johannes Giedl, et al.
Pageof 94

Showing results (521-530 of 933) with videos related to

Sort By:
Pageof 94
Gynecologic Oncology|February 19, 2017
Genetic risk factors for ovarian cancer and their role for endometriosis riskStefanie Burghaus, Peter A Fasching, Lothar Häberle, et al.
International Urology and Nephrology|December 31, 2016
WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approachWolfgang Otto, Johannes Breyer, Sonja Herdegen, et al.
Cancers|September 28, 2024
Tumor-Associated Neutrophils Are a Negative Prognostic Factor in Early Luminal Breast Cancers Lacking Immunosuppressive Macrophage RecruitmentEva Schmidt, Luitpold Distel, Ramona Erber, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|March 3, 2018
Initial clinical results with a fusion prototype for mammography and three-dimensional ultrasound with a standard mammography system and a standard ultrasound probeJulius Emons, Marius Wunderle, Arndt Hartmann, et al.
Oncology|March 14, 2015
Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09)Günter Niegisch, Margitta Retz, Mark Thalgott, et al.
International Journal of Molecular Sciences|September 23, 2022
Improved Bladder Tumor RNA Isolation from Archived Tissues Using Methylene Blue for Normalization, Multiplex RNA Hybridization, Sequencing and SubtypingStefanie A Köhler, Lisa Brandl, Pamela L Strissel, et al.
Cancers|January 1, 2020
Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer PatientsAmer Abdulrahman, Markus Eckstein, Rudolf Jung, et al.
The American Journal of Surgical Pathology|October 9, 2015
Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic MarkerAbbas Agaimy, Katja Specht, Robert Stoehr, et al.
Geburtshilfe Und Frauenheilkunde|July 18, 2017
A Standard Mammography Unit - Standard 3D Ultrasound Probe Fusion Prototype: First ResultsRüdiger Schulz-Wendtland, Sebastian M Jud, Peter A Fasching, et al.
BMC Cancer|March 22, 2014
Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective studyAnja Rogler, Sabine Hoja, Johannes Giedl, et al.
Pageof 94